Creatine

Creatine is an organic acid built from amino acids and found throughout the vertebrate body, with the large majority stored in skeletal muscle ^[1]. Most of it exists either as free creatine or as phosphocreatine, a phosphorylated form that serves as a rapidly available energy reserve ^[3]. The body synthesizes creatine in the liver, kidneys, and pancreas using arginine, glycine, and a methyl group supplied by methionine; a small fraction of the total store is broken down each day to creatinine and excreted, and this loss must be replaced through synthesis or diet ^[1].

Because creatine is concentrated in muscle tissue, dietary intake comes mainly from meat and fish, and people who eat little or no animal food tend to have lower baseline levels ^[1]. The compound was first isolated from skeletal muscle by Michel Eugene Chevreul in 1832 and named after the Greek word for flesh ^[1]. Early twentieth-century research showed that eating creatine could raise its concentration in muscle, and phosphocreatine was later identified as a key player in muscular energy metabolism ^[3].

Creatine is sold as a dietary supplement, most commonly in the well-studied form creatine monohydrate ^[2]. Supplementation reliably increases the creatine and phosphocreatine content of muscle, and when combined with resistance training it has been shown to enhance strength, power, and gains in lean mass beyond training alone ^[1][2]. Regimens often begin with a short loading period of higher daily intake to saturate muscle stores quickly, followed by a smaller ongoing maintenance intake, although a lower steady intake reaches the same stores more gradually ^[3]. Benefits are most pronounced in brief, high-intensity efforts and tend to fade as exercise duration lengthens ^[2].

Beyond sport, creatine has been investigated for a wide range of clinical and cognitive applications, including neurodegenerative and neuromuscular disorders, recovery, and brain energy metabolism ^[1]. Research on cognition has produced mixed results; a 2024 review by the European Food Safety Authority concluded that the current studies do not establish a cause-and-effect relationship between creatine supplementation and improved cognitive function ^[4].

Creatine is regarded as one of the most thoroughly studied sports supplements, and expert reviews describe both short-term and long-term use in healthy people as safe and well tolerated, with no evidence of kidney harm at customary intakes ^[1]. In most countries it is regulated as a dietary supplement or food rather than as a medicine, and it is widely available as a powder, in capsules, and in drink mixes ^[1][2].

Creatine monohydrate is one of the most studied and safest supplements there is, with decades of data and no credible link to kidney or liver harm in healthy people. The common early effects are a few pounds of water weight and occasional bloating or GI upset, worse if you load or take it dry. People with existing kidney disease should clear it with a doctor first. Monohydrate is the gold-standard form; the fancier versions do not beat it and cost more.

The best-characterized creatine interaction is with caffeine: a crossover study by Vandenberghe and colleagues found that caffeine co-ingestion blunted the ergogenic benefit of creatine loading on muscle performance, a pharmacodynamic antagonism at the level of muscle contractile function. Creatine raises serum creatinine as a benign analytical artifact, which can confound interpretation of renal function tests rather than reflect a true drug interaction. Caution combining creatine with nephrotoxic agents (for example NSAIDs or aminoglycosides) is often cited, but this rests on theoretical renal-load reasoning rather than well-documented interaction studies. This is research information, not medical advice.

Checking a whole stack? Run it through interactions + stacks.

Creatine was first isolated from skeletal muscle in 1832 by the French chemist Michel Eugene Chevreul, who named it after the Greek word kreas, meaning flesh. Nineteenth and early twentieth century physiologists gradually pieced together its role in energy metabolism, discovering phosphocreatine and the creatine kinase reaction that regenerates ATP during bursts of intense effort.

Creatine's leap into mainstream use came in the early 1990s, when researchers including Roger Harris and Paul Greenhaff published influential work showing that oral supplementation markedly raised muscle creatine stores and improved high-intensity performance. Public attention surged after the 1992 Barcelona Olympics, where several medal-winning athletes were reported to use it, sparking a commercial boom in creatine monohydrate powders. Today creatine is among the most extensively researched dietary supplements in the world, with a strong safety record and expanding investigation into brain and metabolic health.

Creatine monohydrate enjoys an almost unique standing in sports nutrition: it is widely considered the most effective and best-evidenced legal supplement for increasing strength and repeated high-intensity performance. Its safety profile is reassuring, supported by decades of studies and long-term use in athletes, and the compound is inexpensive and simple to dose. Enthusiasm has broadened well beyond the gym, as researchers explore its potential to support brain energy metabolism, cognition under stress such as sleep deprivation, recovery from traumatic brain injury, and healthy aging. The honest boundary is that while its ergogenic benefits are firmly established, the cognitive and neuroprotective effects remain promising but not yet proven, and individual response to muscle loading varies. Even so, few supplements combine this much positive evidence with such a benign risk profile.